Regulatory Decision-making on COVID-19 Vaccines During a Public Health Emergency

JAMA. 2020 Oct 6;324(13):1284-1285. doi: 10.1001/jama.2020.17101.

Authors

Jerry Avorn¹, Aaron Kesselheim¹

Affiliation

¹ Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

PMID: 32870268
DOI: 10.1001/jama.2020.17101

No abstract available

MeSH terms

Betacoronavirus
COVID-19
COVID-19 Vaccines
Coronavirus Infections / prevention & control*
Government Regulation*
Humans
Pandemics / prevention & control*
Pneumonia, Viral / prevention & control*
Public Health
SARS-CoV-2
United States
United States Food and Drug Administration
Viral Vaccines*

Substances

COVID-19 Vaccines
Viral Vaccines